[1]宋雪凌,马彩虹,李蓉,等.腹腔镜卵巢打孔联合经阴道未成熟卵泡穿刺术治疗难治性多囊卵巢综合征的疗效观察[J].中国微创外科杂志,2017,17(5):388-392.
　Song Xueling,Ma Caihong,Li Rong,et al.Effects of Laparoscopic Ovarian Drilling Combined with Transvaginal Immature Follicle Aspiration on Refractory Polycystic Ovary Syndrome[J].Chinese Journal of Minimally Invasive Surgery,2017,17(5):388-392.
点击复制

腹腔镜卵巢打孔联合经阴道未成熟卵泡穿刺术治疗难治性多囊卵巢综合征的疗效观察()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
17
期数:
2017年5期
页码:
388-392
栏目:
临床论著
出版日期:
2017-07-14

文章信息/Info

Title:
Effects of Laparoscopic Ovarian Drilling Combined with Transvaginal Immature Follicle Aspiration on Refractory Polycystic Ovary Syndrome
作者:
宋雪凌; 马彩虹; 李蓉; 杨蕊; 张佳佳; 杨硕; 杨艳; 卢翠玲; 乔杰**
北京大学第三医院生殖医学中心，北京100083
Author(s):
Song Xueling;  Ma Caihong;  Li Rong;  et al.
Center of Reproductive Medicine, Peking University Third Hospital, Beijing 100083, China
关键词:
多囊卵巢综合征; 卵巢打孔术; 未成熟卵穿刺术
Keywords:
Polycystic ovary syndrome; Ovarian drilling; Immature follicle aspiration
文献标志码:
A
摘要:
目的评估难治性多囊卵巢综合征(polycystic ovary syndrome，PCOS）行腹腔镜卵巢打孔（laparoscopic ovarian drilling,LOD）联合经阴道未成熟卵泡穿刺术（immature follicle aspiration,IMFA）的疗效。方法2014年9月~2016年7月，共纳入拟行LOD的难治性PCOS 124例。术前依据患者的意愿，愿意LOD术中同时行IMFA获取未成熟卵者行LOD+IMFA手术，共83例，不愿意同时获卵者仅行LOD手术，共41例。比较2组性激素水平包括促黄体生成素（LH）、雄烯二酮（A）、游离雄激素指数（FAI）、抗缪勒管激素（AMH）等。随访6~12个月，观察自然排卵恢复、促排卵治疗效果及妊娠情况。结果2组术后第1次月经期LH、A、AMH均比术前显著下降（P<0.05），2组之间比较差异无显著性(P>0.05)。恢复自然排卵的比例LOD+IMFA组39.8%（33/83），LOD组34.1%（14/41），2组差异无显著性（χ2=0.367，P=0.544）。对未恢复排卵者进行促排卵治疗，LOD+IMFA组排卵率［78.0%（39/50）］显著高于LOD组［37.0%（10/27）， χ2=12.713，P=0.000］。2组临床妊娠率差异无显著性［446%（29/65） vs. 32.3%（10/31）， χ2=1.329，P=0.249］。LOD+IMFA组98.8%（82/83）获得成熟卵。结论LOD+IMFA治疗难治性PCOS安全有效，术中同时获得未成熟卵为患者进行生育力储备。
Abstract:
ObjectiveTo observe the changes and effects of laparoscopic ovarian drilling (LOD) combined with transvaginal immature follicle aspiration (IMFA) on patients with refractory polycystic ovary syndrome (PCOS).MethodsA total of 124 patients with refractory PCOS from September 2014 to July 2016 were recruited in this study. According to patients’ consents prior to the surgery, 83 patients who preferred to receive ultrasound guided IMFA followed by LOD were enrolled in LOD+IMFA group, while 41 patients who refused to take IMFA were recruited into the LOD group, receiving laparoscopy and ovarian drilling only. Serum hormone levels, including luteinizing hormone (LH), androstenedione (A), free androgen index (FAI) and anti-mullerian hormone (AMH), were evaluated before surgeries. In the following 6-12 months, spontaneous resumption of menstruation, ovulation-stimulation treatment effects, and pregnancy rates were monitored in the two groups.ResultsSerum levels of LH, A, AMH in both groups were decreased significantly after surgeries compared to the levels before surgeries(P<0.05), and no significant differences were found between the two groups(P>0.05). There was no significant difference in the rates of resumption of menstruation between the two groups ［39.8% (33/83) in LOD+IMFA group, and 34.1% (14/41) in LOD group, respectively, χ2=0.367, P=0544］. However, after ovulation induction treatment, the ovulation rate in LOD+IMFA group ［78.0% (39/50)］ was significantly higher than that in LOD group ［37.0% (10/27), χ2=12.713, P=0.000］. The pregnancy rate had no significant difference between the two groups ［44.6% (29/65) vs. 323% (10/31), χ2=1.329, P=0.249］. In LOD+IMFA group, 98.8% (82/83) patients acquired mature oocytes.ConclusionsLOD+IMFA treatment for refractory PCOS is safe and efficient. The immature oocytes obtained in the surgery can be stored for patients’ fertility preservation.

参考文献/References:

[1]Hueb CK,Dias Júnior JA,Abro MS,et al.Drilling: medical indications and surgical technique.Rev Assoc Med Bras (1992),2015,61(6):530-535.
[2]李红真，乔杰.来曲唑与克罗米芬对多囊卵巢综合征妇女促排卵及生殖激素变化的影响.中国临床药理学杂志，2012,28（7）:502-504.
[3]Ghomian N,Khosravi A,Mousavifar N,et al.A randomized clinical Trial on comparing The cycle characteristics of two different Initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles.Int J Fertil Steril,2015,9(1):17-26.
[4]梁晓燕，庄广伦，周灿权.难治性多囊卵巢综合征的治疗策略及结局.中华妇产科杂志，2000，35（10）:591-593.
[5]Costello MF,Ledger WL.Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology.Womens Health (Lond),2012,8(3):291-300.
[6]Kong GW,Cheung LP,Lok IH.Effects of laparoscopic ovarian drilling in treating infertile anovulatory polycystic ovarian syndrome patients with and without metabolic syndrome.Hong Kong Med J,2011,17(1):5-10.
[7]陈子江，李媛，赵力新,等.超声下未成熟卵泡抽吸术治疗多囊卵巢综合征不孕的临床研究.中华妇产科杂志，2005，40（5）：295-297.
[8]Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15(7):539-553.
[9]中华人民共和国卫生部疾病控制司.中国成年人超重和肥胖症预防控制指南.第1版.北京：人民卫生出版社，2003.3
[10]孙玲，陈士玲.PCOS的诊断及鉴别诊断.见：乔杰，主编.多囊卵巢综合征.第1版.北京：北京大学医学出版社，2010.88-95.
[11]Legro RS,Barnhart HX,Schlaff WD，et al．Clomiphene,metformin,or both for infertility in the polycystic ovary syndrome．N Engl J Med，2007，356(6)：551-566.
[12]Dumont A,Robin G,Catteau-Jonard S,et al.Role of anti-Müllerian hormone in pathophysiology,diagnosis and treatment of polycystic ovary syndrome:a review.Reprod Biol Endocrinol,2015,13:137.
[13]Giampaolino P,Morra I,Della Corte L,et al.Serum anti-Mullerian hormone levels after ovarian drilling for the second-line treatment of polycystic ovary syndrome:a pilot-randomized study comparing laparoscopy and transvaginal hydrolaparoscopy.Gynecol Endocrinol,2017,33(1):26-29.
[14]Pinola P,Puukka K,Piltonen TT,et al.Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.Fertil Steril,2017 Jan 12.［Epub ahead of print］
[15]Qiao J,Wang ZB,Feng HL,et al.The root of reduced fertility in aged women and possible therapentic options:current status and future perspects.Mol Aspects Med,2014,38:54-85.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金海外及港澳合作基金（31429004）；院内临床重点支持项目（Y67437-10）**通讯作者，E-mail：jie.qiao@263.net
更新日期/Last Update: 2017-07-14